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Abstract 
Objective:  The objective of this study was to develop and evaluate a process for integrating components of medication therapy 
management services into a community pharmacy workflow.  Secondary objectives were to evaluate outcomes as well as patient and 
pharmacist satisfaction with this change. Methods: This prospective, 3-month observational study took place in a small, independent 
community pharmacy.  This intervention included a redesigned work system that included a seated private desk area and focus on 
the pharmacist, rather than the technician, being the first contact when patients entered the pharmacy. Pharmacists participated in 
a focus group before and after the implementation of the new workflow to better understand the delivery of the intervention and 
assess satisfaction. Process outcomes included time spent with the patient, the number of medication-related problems identified 
and recommendations made, the type of disease education provided, type and number of immunizations administered, and health 
monitoring tests performed.  Patient satisfaction surveys were distributed after completing the intervention during the third month of 
the study. Results: A total of 56 patients were enrolled in this study resulting in 82 encounters.  Forty medication-related problems, 
including experiencing an adverse drug reaction and ineffective therapy, were identified with recommendations made to patients or 
prescribers.  Disease education, such as goals of therapy, was provided 46 times.  Health monitoring tests, such as blood pressure, 
were performed 16 times and eight immunizations were administered.  The revised workflow incorporating components of MTM 
services was successful in that 39% of encounters were less than two minutes and 49% of encounters were between two and five 
minutes in length.  Only 12% of encounters were greater than five minutes.  Overall, patients were very satisfied with the 
intervention.  Pharmacists responded positively, but expressed concern that the changes to the work system prevented them from 
overseeing technician functions. Conclusion: Pharmacists in community practice are able to provide components of medication 
therapy management services during a brief, face-to-face interaction with patients.  Overall, patients and pharmacists were satisfied 
with the changes to the pharmacy work system and that additional work system changes are needed to further expand the role of 




Medication-related problems are a significant burden to the 
United States health care system.1-3  In 2001, the annual drug 
related morbidity and mortality was estimated to be 
approximately $177 billion.4  Medication-related problems 
can be classified into various categories including: 
unnecessary drug therapy, ineffective drug therapy, 
additional drug therapy needed, drug interactions, drug  
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contraindications, non-adherence to drug therapy, and 
adverse drug reactions.5-7 These medication-related problems 
are able to be identified and resolved by pharmacists in the 
community pharmacy practice setting.8-10 
 
The scope of pharmacy practice in community settings has 
expanded considerably in recent years with the addition of 
medication therapy management (MTM) services as one 
major driver of this expansion.  The consensus definition for 
MTM covers a wide array of patient care services including 
medication therapy reviews, disease education and 
management, health and wellness, pharmacogenomics, 
anticoagulation management, pharmacotherapy consults, 
and immunizations.11  Pharmacists’ involvement in helping 
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patients improve patient management of diabetes, asthma, 
anticoagulation, hypertension, and hyperlipidemia have been 
documented in the literature.12-16  
 
Despite the benefits of these pharmacist services, the 
provision of MTM has not been widespread in the community 
pharmacy setting due to challenges related to integration of 
these services into the workflow of the pharmacy.  Workflow, 
as described in this paper, is the step-by-step process used to 
fulfill a prescription order for a patient.  A recent study 
determined that pharmacists interacted with 25.0% of the 
patients that were picking up prescriptions at the walk-in 
window.  Pharmacists spent 143 + 84 seconds counseling 
patients.17  The design of the pharmacy work system is 
identified as a major barrier to facilitating patient-pharmacist 
interaction.  Implementation of new and emerging care 
models depends on themes related to environment, 
organization, philosophy of practice, a patient care process, 
and clinical knowledge.18-20  Schommer et al identifies work 
system design, entrepreneurial orientation, and 
organizational flexibility as the key components to provide 
MTM.21  Other reasons that pharmacists’ do not providing 
patient counseling have been studied extensively in the 
literature.  Major themes of this research include lack of 
compensation for services, excessive workload, physical 
layout and lack of patient demand.22-24 These factors were 
considered during the conceptualization of this study. 
 
Providing MTM services are separate from the dispensing 
function of the pharmacist and patients receive MTM on an 
appointment basis.12-16 This could be one reason for the lack 
of widespread adoption of these services.  This project will 
evaluate if components of MTM services can be integrated 
into the community pharmacy workflow.  This would allow 
increased access to MTM services for patients and act as a 




The objective of this study was to develop and evaluate a 
process for integrating components of MTM services into a 
community pharmacy workflow.  Secondary objectives were 
to evaluate outcomes as well as patient and pharmacist 
satisfaction with the work system changes.  This study was 
approved by the Institutional Review Board at Virginia 
Commonwealth University.  
 
Study Design 
This was a prospective 3-month observational study 
conducted at an independent community pharmacy in 
Richmond, VA.  The pharmacy fills approximately 70 
prescriptions per day and is staffed at any given time by one 
pharmacist and two technicians.  There are three relief 
pharmacists who work part-time at the pharmacy.  Other 
services provided by this pharmacy include compounding, 
travel immunizations, and comprehensive appointment-
based MTM. This study consisted of a pre- and post- study 
focus group with pharmacy team members, an intervention 
period, and a patient satisfaction survey.  A focus group guide 
was developed with questions to identify the perceived 
benefits of providing the service, anticipated challenges, and 
impact of the change on patients. The guide was reviewed 
and revised for clarity by investigators (JG, LM) with 
experience in conducting focus groups. An investigator (CL) 
conducted the pre-study focus group to discuss the proposed 
work system changes and evaluate the benefits and barriers 
to providing the service.  The session was video recorded and 
transcribed verbatim.  Content analysis was used to analyze 
the results of the focus group.  This information was used to 
aid the development of the new workflow process to 
integrate components of MTM services. The components of 
MTM services to be integrated into the workflow were 
medication therapy reviews, disease education, lifestyle 
modifications, health monitoring tests and immunizations.  
 
Workflow Process, Work System Changes, and Service 
Intervention 
Prior to this study, technicians were primarily responsible for 
greeting patients when they entered the pharmacy to pick-up 
prescriptions.  The technician would offer the patient 
counseling by the pharmacist and collect payment for the 
prescriptions.  If a patient indicated they wanted counseling, 
the pharmacist was called over to talk with the patient at the 
register. 
 
The workflow was redesigned to promote pharmacist 
engagement with patients.  After prescription verification by 
the pharmacist, a pharmacy technician entered prescription 
information into the patient pharmacy record before placing 
the completed prescriptions into the will-call bins.  Each 
patient record was saved and accessed by pharmacists when 
patients picked up their prescriptions.  As patients entered 
the pharmacy, the pharmacist greeted patients and collected 
patient prescriptions from the will-call bin.  The pharmacist 
directed the patient to the seated desk area that was 
constructed to perform the intervention.  Patients were auto-
enrolled when they picked-up prescriptions at the pharmacy 
unless they indicated they asked the pharmacist to skip the 
service.  The intent was to conduct the service for all patients 
in the pharmacy; however, participation by pharmacists was 
voluntary. Not all patients entering the pharmacy during the 
study period were provided this service. 
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Pharmacists did not address all aspects of the intervention at 
each visit.  Pharmacists were encouraged to talk about 
different aspects of the patient’s medications and health each 
time and identify appropriate follow-up to any problems 
documented from a previous encounter.  An encounter was 
defined as a sit-down interaction between patient and 
pharmacist.  An intervention was defined as providing a 
recommendation to solve a medication-related problem, 
providing disease or health education, administering an 
immunization, or providing a health monitoring test.  A 
pharmacy technician collected payment for the prescriptions 
at the cash register terminal after the pharmacist completed 
the encounter.   
 
Pharmacists first focused discussion on the medications that 
patients were picking up during that visit to the pharmacy.  
This included discussion related to how patients were taking 
their medications, what the medications were being used for, 
how the medication works, and potential adverse reactions 
that could occur.  Patients were also asked to demonstrate 
proper injection technique and demonstrate that medical 
devices were being used properly, if applicable.  Pharmacists 
documented where patients stored their medications.  
Through these questions, pharmacists attempted to identify 
and make recommendations for any medication-related 
problems.  The seven categories of medication-related 
problems could be documented by pharmacists.  These 
included unnecessary medication(s), additional medication(s) 
needed, ineffective medications, contraindications, 
interactions, non-adherence, and adverse drug reactions 
experienced.  Pharmacists took steps to resolve medication-
related problems through a recommendation directly to the 
patient, an offer to contact the patient’s physician directly, or 
a recommendation that the patient follow-up with their 
physician. 
 
Pharmacists also provided patients with education about 
their diseases specific to the prescriptions being picked up at 
that encounter.  Pharmacists inquired about patient medical 
history and lifestyle habits to make evidence-based 
recommendations for a patient’s goals of therapy and 
lifestyle choices.  Pharmacists provided education related to 
disease progression and signs or symptoms of uncontrolled or 
worsening disease.   
 
The pharmacist provided health monitoring tests based on 
current medications and diseases.  These included measuring 
blood pressure and pulse.  Pharmacists also screened patients 
for immunization-related needs and administered 
immunizations when appropriate.  Current Center for Disease 
Control and Prevention immunization guidelines were used to 
determine eligibility of each patient for immunizations.25  
A laptop computer at the pharmacist desk was used as part of 
the patient care documentation.  This computer was 
connected to a secure, password protected, wireless network 
through the pharmacy.  Pharmacists logged on to the 
computer through remote desktop connection which allowed 
access to a HIPAA compliant hard drive.  This hard drive 
stored enrolled patient’s pharmacy records on a Microsoft 
Excel spreadsheet.  
 
After completion of the intervention for an encounter, 
pharmacists were asked to record the type of interventions 
made using an anonymous web-based tracking form created 
using Google Form.  Pharmacists also estimated the amount 
of time spent with patients during the encounter.  Outcomes 
data was collected in this manner and aided the data 
collection and analysis process.  
 
A paper patient satisfaction survey was distributed to 
patients’ in-person who completed an intervention during the 
final month of the study period.  Basic demographic 
information, including age and gender, were collected about 
survey participants.  Survey participants were asked how 
many years they had been a customer at the pharmacy and 
the number of prescriptions they used.  The survey consisted 
of ten statements that asked patients to evaluate their 
satisfaction with the changes to workflow.  The items were in 
a 5-point Likert scale format.  
 
The pharmacy team met in a post-study focus group to 
evaluate the changes, discuss the benefits and barriers, and 
develop a plan for continuing the service in the future.  This 
session was video recorded and results transcribed verbatim. 




Pre-intervention Focus Group 
A total of 5 pharmacy team members participated in the 
focus group.  This included one pharmacist-in-charge, two 
clinical pharmacist coordinators, and one certified pharmacy 
technician. 
 
Overall, the pharmacists felt the proposed work system 
changes would be positive and help increase patient 
awareness about the knowledge and skills of a pharmacist.  
Concerns with patient participation, related to time for and 
purpose of the service, were brought up and cited as a 
potential barrier to providing patients with this service.  One 
pharmacist summarizes this below: 
 
‘Pharmacy is going to change and I think this is a good way to 
start the process of changing patients mind of what a 
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pharmacy is and what [pharmacists] do.  I do feel like there’s 
gonna be some people that are like I don’t have time for this 
and why are you doing this.’ 
 
Documentation procedures for the new service were 
discussed with the pharmacists and technician.  One 
pharmacist pointed out that patient interactions are not 
currently documented.  Pharmacists agreed that there was 
not currently a good system for documenting patient 
encounters.  The use of a computer spreadsheet was viewed 
as a positive step in that direction. 
 
‘I definitely think documentation of what we’re doing as 
pharmacists when we talk to patients at the time of pick-up.  I 
don’t think there is a streamline for that.  We don’t document 
that now unless there’s a problem.’ 
 
Pharmacists discussed the possibility of using the results of 
this study as evidence when proposing legislation for 
pharmacists to be compensated for their time spent 
delivering direct patient care services.  Pharmacists felt it was 
important for pharmacy to be recognized for their services 
and compensated appropriately.  Pharmacists noted that 
without current documentation it made it difficult to justify. 
 
‘We can show our value down the line when we need 
information sent to public officials who are, you know, 
passing a law.  Here is what we do in our pharmacy and here 
are the results.’ 
 
Intervention 
A total of 56 patients were enrolled in the study resulting in 
82 total patient encounters.  Twenty-seven of these patients 
were male (48.2%).  The average age of the patients was 
61.8+20.0 years.   Data was collected from January 2013 
through the beginning of April 2013. 
 
An average of 1.3 interventions were provided per patient 
encounter. There were 40 medication-related problems 
identified during the three month intervention period (figure 
1).  The most commonly identified medication-related 
problem was the patient experiencing an adverse drug 
reaction, while the least commonly identified problem was 
improper use of a medical device.  
 
Recommendations were made by pharmacists when a 
medication-related problem was identified.  Of these 
recommendations, 77.5% (n=31) were made directly to the 
patient (e.g. correct use of inhaler).  Another 12.5% (n=5), 
required the pharmacist to fax a recommendation to the 
prescribing physician and 10% (n=4) of the medication-
related problems identified resulted in asking the patient to 
follow-up with the physician. 
 
Pharmacists provided disease-related education a total of 46 
times.  This included pharmacists talking with patients about 
their goals of therapy (e.g., A1c, blood pressure, cholesterol) 
on 21 encounters.  Pharmacists also provided patients with 
information on how to tell if their disease was poorly 
controlled or progressing (n=13).  Less commonly pharmacists 
talked with patients about making healthier food choices 
(n=9) and the benefits of exercising (n=3). 
 
Pharmacists administered a total of eight immunizations (two 
herpes zoster vaccines and six influenza vaccines).  Others 
were screened by pharmacists, but patients opted to ‘think 
about it’ or ‘check with their physician.’  Health monitoring 
tests including blood pressure and pulse were performed 16 
times.   
 
Pharmacists estimated the amount of time spent with 
patients during each encounter.  Of the encounters, 39.0% 
were less than two minutes in length (n=32) and 48.8% were 
between two and five minutes in length (n=40).  Time with 
patients between six and ten minutes in length accounted for 
9.8% of encounters (n=8).  Finally, 2.4% of all encounters 
were reported to be greater than ten minutes in length (n=2). 
 
Patient Satisfaction Survey 
A total of 22 surveys were distributed and all were returned.  
Table 1 summarizes the demographic information for survey 
respondents.  The results of the satisfaction survey are found 
in table 2 and reports how satisfied patients were related to 
the changes in pharmacy workflow.   
 
Overall, patients were satisfied with the changes to the 
workflow.  Patients felt that sitting down to talk with the 
pharmacist was beneficial and most agreed that they learned 
something new as a result of talking to the pharmacist.  
Patients also felt that the conversations were more private 
than before this change. 
 
Post-study focus group 
Two pharmacists and an investigator (CL) met after the 
completion of the intervention period to evaluate the work 
system changes, discuss the impact of the service and 
determine the future of the intervention.  Due to a schedule 
conflict, another pharmacist participated in a one-on-one 
interview with the investigator. The pharmacy technician did 
not attend the post-study focus group.  Pharmacists indicated 
that the service was of value to the patient and overall 
improved the quality of care for patients.  Pharmacists felt 
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they were contributing to improved medication use for 
patients who were involved with this intervention. 
 
‘The interaction with the patient in actually identifying things 
that would not have been identified, had we not sat down to 
talk about [their medications].’ 
 
Pharmacists concluded as a group that a major barrier to the 
intervention was the lack of integration between the 
dispensing software and documentation program in 
Microsoft Excel.  One pharmacist noted the apprehension to 
talk with patients due to the fear that the documentation 
system was not going to be accessible. 
 
‘I agree that in the beginning, figuring out the computer even 
though it was up and running like there were times where I’d 
go and something was wrong and so I couldn’t do it and it 
was kind of like uh, you have that hold back of well there 
might be an issue and I don’t want to have an issue so that 
was kind of a barrier to go to that other system.’ 
 
Pharmacists indicated that they would like to continue 
providing this service.  Pharmacists agreed that they enjoyed 
the more structured conversations with patients.  Concerns 
were expressed over being removed from the traditional 
dispensing role.  The inability of the pharmacist to oversee 
technician functions was cited as a problem. 
 
‘Since I’m in the position of being the pharmacist-in-charge 
and managing the store, I feel I need to keep a hand in the 
dispensing part to keep an eye out for claims not paid or paid 
under and things like that. Being out there the whole time for 
me, it wouldn’t be comfortable for me since I’m in charge I 
feel like I need to know what everyone is doing.’ 
 
Discussion 
This is the first study to evaluate the integration of 
components of MTM services into the dispensing workflow of 
a community pharmacy.  MTM has been provided by 
community pharmacists for years.  These are typically 
appointment-based interventions in which pharmacists spend 
significant time performing comprehensive MTM services.26-28  
Other studies have focused on specific disease states and 
performed targeted interventions for one disease on an 
appointment basis.9-13  Pharmacists are also compensated for 
providing those MTM services.  This study performed a 
general, brief intervention when a patient arrived to pick up 
prescription medications to target medication-related 
problems, disease education, immunizations, and health 
monitoring tests. 
 
Other studies have reported rates of medication related-
problems in the community pharmacy practice setting.  The 
rates of adverse drug reactions (17.2%) in this study were 
comparable to multiple other studies published.  Ernst et al 
and Cipolle et al reported rates of adverse drug reactions to 
be 17.3% and 21.3%, respectively.8,10  The medication-related 
problem of additional drug therapy needed was lower in this 
study (8.6%) than what has been reported in previous studies 
which has ranged from 23.0% to 56.4%.8-10  This may have 
occurred because the intervention was too short for the 
pharmacist to obtain complete patient medical history or 
laboratory data from a patient’s physician.  It is also possible 
that pharmacists did not assess for this medication-related 
problem for each patient.   
 
Pharmacists in this community practice setting were able to 
identify medication-related problems and provide 
recommendations to patients regarding their medications 
and diseases.  Pharmacists’ recommendations were made 
directly to patients in 77.5% of the cases.  This is comparable 
to another study in which 80% of recommendations were 
made directly to the patient.9 It is unknown whether or not 
the pharmacist recommendations resolved the medication-
related problems.  The majority of these encounters took 
place in less than five minutes indicating that it may be 
possible to provide this service to a higher volume of patients 
without significant wait times.   
 
Patients were satisfied with the changes to the prescription 
pick-up process.  Of note, the majority of patients (n=15) 
have been a customer at the pharmacy for more than 5 years.  
Patients felt that the brief interaction with their pharmacist 
was beneficial to them.  This study demonstrates that 
changes to the pharmacy work system can have a positive 
effect on patients’ perception of pharmacist services. 
 
Pharmacists felt that they were helping patients more directly 
and that the service expanded their ability to improve the 
quality of care.  The documentation of the intervention was 
cited as a barrier by all of the pharmacists due to the lack of 
comfort using the system.  Pharmacists noted the need to 
oversee the rest of the pharmacy made it difficult to provide 
the service to each patient picking up prescription 
medications.  However, this may be the direct result of 
pharmacists not embracing the changes to the work system 
and the perceived need to be directly involved with all 
aspects of the dispensing process.  The above reasons can be 
attributed to the reasons the changes to the workflow were 
not always followed and intervention not performed.  Since 
the pharmacy technician was absent at the post-study focus 
group the impact of the changes from the technician’s 
perspective is not known. 
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This study had a low number of patient encounters due to a 
number of factors.  Buy-in from pharmacy team members for 
providing the intervention was not completely achieved.  
There were no incentives or compensation for pharmacists to 
provide the service and this could be one reason for the low 
number of encounters.  Other factors might include the lack 
of standardized training with the documentation process.  
This might have caused apprehension using the spreadsheet 
and prevented the pharmacist from initiating the 
intervention.  It is still unknown how the pickup process could 
be applied to higher volume pharmacies.  Even with a low 
volume of prescriptions, the intervention was not performed 
for all patients entering the pharmacy.  Changing 
pharmacist’s habits was difficult and pharmacists were not 
required to provide the intervention when a patient picked-
up their prescriptions.  Prescription information had to be 
manually loaded into the Microsoft Excel documentation 
system.  If this was not completed, interventions with 
patients became more difficult as pharmacists would not 
know what medications were being picked-up.  Patients also 
had a varying number of encounters.  Some patients only had 
one intervention while others had multiple interventions.  It 
is unknown how many patients refused the intervention.  The 
satisfaction survey and focus groups were not validated and 
involved only a subset of the study participants. 
 
There are multiple ways in which to improve this study and its 
potential for scalability.  Incorporating documentation of the 
intervention into the current pharmacy management 
software or allowing two software systems to interface would 
allow for a streamlined process and improve the data 
collection process.  Additional expansion of the pharmacy 
work system capacity is another way components of MTM 
services can be further integrated into the community 
pharmacy dispensing process.   
 
Conclusion 
The community pharmacy practice work system can be 
modified so that pharmacists are able to provide components 
of MTM services during a brief, face-to-face interaction with 
patients. Overall, patients were satisfied with the changes to 
the pharmacy work system.  Pharmacists reported concerns 
about the implementation of the changes on their ability to 
carry out the intervention.  Additional work system changes 
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Table 1 – Patient Satisfaction Survey (n=22) 

























Table 2 – Patient Satisfaction Survey Results (n = 22) 
Now that you have been able to participate in the new prescription pick-up process (sitting down with the pharmacist at 
prescription pick-up), please give us feedback on the new process compared to the old process: 
Statement Strongly 
Agree (%) 
Agree (%) Neutral (%) 
The pharmacist helps me in a timely manner 20 (90.9) 2 (9.1) -- 
Sitting down with the pharmacist to discuss my medications is 
beneficial 
18 (81.8) 4 (18.2) -- 
The conversations I have with my pharmacist are more private 13 (59.1) 9 (40.9) -- 
The pharmacist spends an appropriate amount of time with me 16 (72.7) 6 (27.3) -- 
The pharmacist provided me with education about my 
medications 
18 (81.8) 4 (18.2) -- 
The pharmacist provided me with education about my health 
condition(s) 
12 (54.5) 10 (45.5) -- 
I learned something new as a result of the new prescription pick-
up process 
16 (72.7)  5 (22.7) 1 (4.6) 
I am confident that I am taking my medications correctly 15 (68.2) 7 (32.8) -- 
Health monitoring tests performed at the pharmacy are beneficial 
to me 
9 (40.9) 10 (45.5) 3 (13.6) 
I am more comfortable asking the pharmacist questions 16 (72.7) 6 (27.3) -- 
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I am satisfied with the changes to the prescription pick-up process 15 (68.2) 7 (32.8) -- 
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Medication-related Problems (n = 40) 
